Site 113

Durham, North Carolina 27710

1 studies enrolling now · 2 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma, Immune Thrombocytopenia

Studies at this site

• A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) — Recruiting now
• Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months — Completed